Skip to main content

Rydym wedi cadw rhai ffeiliau o'r enw cwcis ar eich dyfais. Y cwcis hyn yw:

  • Hanfodol ar gyfer y safle i weithio
  • Helpu i wella ein gwefan drwy gasglu ac adrodd gwybodaeth am sut rydych chi'n ei defnyddio

Hoffem hefyd arbed rhai cwcis i helpu i deilwra cyfathrebu.

BETA
Rydych yn edrych ar fersiwn wedi'i ddiweddaru o'r gwasanaeth hwn - bydd eich adborth yn ein helpu i'w wella.

Dyfarnu Contract

Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems

  • Cyhoeddwyd gyntaf: 12 Awst 2021
  • Wedi'i addasu ddiwethaf: 12 Awst 2021

Nid yw'r prynwr yn defnyddio'r wefan hon i weinyddu'r hysbysiad.

I gofnodi eich diddordeb neu gael gwybodaeth neu ddogfennau ychwanegol, darllenwch y cyfarwyddiadau yn Nhestun Llawn yr Hysbysiad. (NODER: Nid oes angen ymateb i Hysbysiadau Dyfarnu Contractau a Hysbysiadau Gwybodaeth Ymlaen Llaw fel arfer)

Cynnwys

Crynodeb

OCID:
Cyhoeddwyd gan:
NHS Blood & Transplant
ID Awudurdod:
AA20525
Dyddiad cyhoeddi:
12 Awst 2021
Dyddiad Cau:
-
Math o hysbysiad:
Dyfarnu Contract
Mae ganddo ddogfennau:
Nac Ydi
Wedi SPD:
Nac Ydi
Mae ganddo gynllun lleihau carbon:
AMH

Crynodeb

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.

The requirement for this procurement was to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004888.

As a result of the tender, a Framework Agreement for Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems for a period of 2 years with two 1-year options to extend has been awarded to Therakos (UK) Ltd.

The following contracting authorities will be able to purchase against the Framework Agreement: NHSBT and Scottish National Blood Transfusion Service.

Testun llawn y rhybydd

Hysbysiad dyfarnu contract

Canlyniadau'r weithdrefn gaffael

Adran I: Endid contractio

I.1) Enw a chyfeiriad

Nhs Blood & Transplant

500-600 North Bristol Park, Northway Bristol, Filton

BRISTOL

BS347QH

UK

E-bost: marta.drozdzowska@nhsbt.nhs.uk

NUTS: UK

Cyfeiriad(au) rhyngrwyd

Prif gyfeiriad: https://www.nhsbt.nhs.uk/

I.4) Y math o awdurdod contractio

Corff a lywodraethir gan gyfraith gyhoeddus

I.5) Prif weithgaredd

Iechyd

Adran II: Gwrthrych

II.1) Cwmpas y caffaeliad

II.1.1) Teitl

Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems

Cyfeirnod: NHSBT1366 / C39664

II.1.2) Prif god CPV

33140000

 

II.1.3) Y math o gontract

Cyflenwadau

II.1.4) Disgrifiad byr

The award is for Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems

Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004888.

Please see section II.2.4 for detailed description of the procurement.

II.1.6) Gwybodaeth am lotiau

Mae’r contract hwn wedi’i rannu’n lotiau: Na

II.1.7) Cyfanswm gwerth y caffaeliad

Gwerth heb gynnwys TAW: 3 050 000.00 GBP

II.2) Disgrifiad

II.2.2) Cod(au) CPV ychwanegol

33693000

50421000

II.2.3) Man cyflawni

Cod NUTS:

UK

II.2.4) Disgrifiad o’r caffaeliad

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.

The requirement for this procurement was to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004888.

As a result of the tender, a Framework Agreement for Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems for a period of 2 years with two 1-year options to extend has been awarded to Therakos (UK) Ltd.

The following contracting authorities will be able to purchase against the Framework Agreement: NHSBT and Scottish National Blood Transfusion Service.

II.2.5) Meini prawf dyfarnu

Price

II.2.11) Gwybodaeth am opsiynau

Opsiynau: Na

II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd

Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd: Na

Section IV: Gweithdrefn

IV.1) Disgrifiad

IV.1.1) Y math o weithdrefn

Gweithdrefn agored

IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)

The procurement is covered by the Government Procurement Agreement: Ydy

IV.2) Gwybodaeth weinyddol

IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon

Rhif yr hysbysiad yn OJ S:

2020/S 230-568414

Section V: Dyfarnu contract

Rhif Contract: NHSBT1366 / C39664

Teitl: Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems

Dyfernir contract/lot: Ydy

V.2 Dyfarnu contract

V.2.1) Y dyddiad y daeth y contract i ben

01/08/2021

V.2.2) Gwybodaeth am dendrau

Nifer y tendrau a ddaeth i law: 1

Dyfarnwyd y contract i gr?p o weithredwyr economaidd: Na

V.2.3) Enw a chyfeiriad y contractwr

Therakos (UK) Ltd

Staines

TW18 3AG

UK

NUTS: UK

BBaCh yw’r contractwr: Ydy

V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)

Cyfanswm gwerth y contract/lot: 3 050 000.00 GBP

V.2.5) Gwybodaeth am is-gontractio

Section VI: Gwybodaeth ategol

VI.4) Gweithdrefnau adolygu

VI.4.1) Corff adolygu

NHS Blood and Transplant

Bristol

UK

VI.5) Dyddiad anfon yr hysbysiad hwn

11/08/2021

Codio

Categorïau nwyddau

ID Teitl Prif gategori
33693000 Cynhyrchion therapiwtig eraill Cynhyrchion meddyginiaethol amrywiol
33140000 Defnyddiau traul meddygol Cyfarpar meddygol
50421000 Gwasanaethau atgyweirio a chynnal a chadw cyfarpar meddygol Gwasanaethau atgyweirio a chynnal a chadw cyfarpar meddygol a llawfeddygol

Lleoliadau Dosbarthu

ID Disgrifiad
100 DU - I gyd

Cyfyngiadau Rhanbarthol ar y Rhybuddion

Mae’r prynwr wedi cyfyngu’r rhybuddion ar gyfer yr hysbysiad hwn i gyflenwyr yn y rhanbarthau canlynol.

ID Disgrifiad
Nid oes cyfyngiadau ar y rhybuddion ar gyfer yr hysbysiad hwn.

Ynglŷn â'r prynwr

Prif gyswllt:
marta.drozdzowska@nhsbt.nhs.uk
Cyswllt gweinyddol:
N/a
Cyswllt technegol:
N/a
Cyswllt arall:
N/a

Gwybodaeth bellach

Dyddiad Manylion
Nid oes unrhyw wybodaeth bellach wedi'i lanlwytho.

0800 222 9004

Mae'r llinellau ar agor rhwng 8:30am a 5pm o ddydd Llun i ddydd Gwener.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.